Skip to content

  • Current Fragile X Research Grants
  • Personal Campaigns
  • Request For Applications – Research Grants
FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome

FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome

Accelerating Fragile X Research for Effective Treatments

Donate
  •  Home
  • What is Fragile X?
    • What Is Fragile X Syndrome?
      • Symptoms
      • Physical Signs
      • Prevalence and Inheritance
      • Fragile X and Autism
      • Treatment
      • Additional Resources
    • What Causes Fragile X Syndrome?
      • The Fragile X Gene
      • Testing/Diagnosis
        • Prenatal Testing
      • Fragile X-Associated Disorders – FXTAS and FXPOI
    • #FriendofFRAXA
      • #FriendofFRAXA Submission
  • News & Updates
  • Research
    • How Close Are We?
    • Funded Research Grants
    • Clinical Trials
    • How to Apply for Research Grants
    • Resources for Researchers
  • Get Involved
    • Events
    • Personal Fundraising Campaigns
    • Clinical Trials
    • Fragile X Clinics
    • FRAXA Volunteer Ambassadors
    • Subscribe to Newsletter
    • Volunteer for FRAXA
    • Fragile X Advocacy
    • FRAXA Shop
    • Share Your Pictures or Videos With Us
  • About FRAXA
    • Mission Statement
    • Give with Confidence
    • Financial Reports
    • FRAXA in the News
    • Board & Leadership
    • Scientific Advisors
    • FRAXA’s Fragile X Timeline
  • Donate
    • Donate Online
    • Monthly Giving Program
    • Give to a Personal Campaign
    • Other Ways to Give

Post Categories

  • Fragile X Clinical Trials
  • Community
  • Upcoming Events
  • #FriendofFRAXA
  • Treatment
  • Educational Strategies
  • Events Recap
  • Research Updates
  • Resources for Researchers
  • Fragile X Advocacy

FRAXA Funded Research

Research Type

Researcher

Research Organization

Grant Year

Grant Status

Mato Santos, Susana

Targeting the Endocannabinoid System in Adult Fragile X Mice

FRAXA Research Foundation September 15, 2014May 17, 2020
Andres Ozaita, PhD

With a $90,000 grant from the FRAXA Research Foundation from 2013-2014, Dr. Andres Ozaita led a team to test rimonabant’s ability to blockade the CB1 receptor. Blocking CB1 has shown potential to reverse most symptoms of disease in mice bred to mimic Fragile X syndrome.

Read more

FRAXA Research Foundation

  • 10 Prince Place, Suite 203
    Newburyport, MA 01950-2657
  • info@fraxa.org
  • (978) 462-1866
Donate Online
GuideStar_Exchange-Platinum_Participant
GreatNonprofits-2022-top-rated-award-FRAXA.png
charity_navigator-4_star_charity

Join our Newsletter Mailing List

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2023 FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome
FRAXA Research Foundation is a registered 501(c)3 organization.
Tax ID: 04-3222167

  • Privacy Policy
  • Cookie Policy
  • About Fragile X
  • Get Involved
  • Ways to Give